Independent Investors Inc. lowered its place in shares of Johnson & Johnson (NYSE:JNJ) by eight.eight% within the second quarter, in accordance with its most up-to-date submitting with the SEC. The fund owned 88,333 shares of the corporate’s inventory after promoting eight,500 shares through the quarter. Johnson & Johnson contains roughly 5.1% of Independent Investors Inc.’s holdings, making the inventory its 2nd largest holding. Independent Investors Inc.’s holdings in Johnson & Johnson had been price $11,685,00zero on the finish of the newest quarter.
Several different hedge funds and different institutional traders have additionally not too long ago purchased and bought shares of JNJ. Lenox Wealth Advisors Inc. lifted its place in shares of Johnson & Johnson by zero.6% through the second quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the corporate’s inventory price $116,00zero after buying a further 5 shares over the last quarter. Harel Insurance Investments & Financial Services Ltd. elevated its stake in shares of Johnson & Johnson by 241.zero% through the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,190 shares of the corporate’s inventory valued at $149,00zero after shopping for a further 841 shares through the interval. Ullmann Financial Group Inc. bought a brand new place in shares of Johnson & Johnson through the first quarter valued at $186,00zero. Taylor Wealth Management Partners elevated its stake in shares of Johnson & Johnson by 19.eight% through the first quarter. Taylor Wealth Management Partners now owns 1,510 shares of the corporate’s inventory valued at $188,00zero after shopping for a further 250 shares through the interval. Finally, Puplava Financial Services Inc. bought a brand new place in shares of Johnson & Johnson through the second quarter valued at $202,00zero. Hedge funds and different institutional traders personal 65.93% of the corporate’s inventory.
Johnson & Johnson (NYSE:JNJ) opened at $138.00 on Friday. The firm has a market capitalization of $370,739.75, a PE ratio of 19.33, a PEG ratio of two.80 and a beta of zero.82. The firm has a debt-to-equity ratio of zero.36, a present ratio of 1.32 and a fast ratio of 1.02. Johnson & Johnson has a 1-year low of $109.32 and a 1-year excessive of $144.35.
Johnson & Johnson (NYSE:JNJ) final posted its quarterly earnings information on Tuesday, October 17th. The firm reported $1.90 earnings per share for the quarter, topping badysts’ consensus estimates of $1.80 by $zero.10. The firm had income of $19.65 billion through the quarter, in comparison with badysts’ expectations of $19.29 billion. Johnson & Johnson had a return on fairness of 27.38% and a internet margin of 21.28%. The agency’s income for the quarter was up 10.three% on a year-over-year foundation. During the identical interval final 12 months, the agency earned $1.68 EPS. sell-side badysts forecast that Johnson & Johnson will publish 7.28 earnings per share for the present 12 months.
The firm additionally not too long ago disclosed a quarterly dividend, which shall be paid on Tuesday, December 12th. Investors of file on Tuesday, November 28th shall be issued a dividend of $zero.84 per share. The ex-dividend date of this dividend is Monday, November 27th. This represents a $three.36 annualized dividend and a yield of two.43%. Johnson & Johnson’s dividend payout ratio is presently 58.33%.
COPYRIGHT VIOLATION NOTICE: This story was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you might be accessing this story on one other web site, it was illegally stolen and reposted in violation of U.S. & worldwide copyright & trademark legislation. The authorized model of this story will be seen at https://ledgergazette.com/2017/11/19/johnson-johnson-jnj-stake-lessened-by-independent-investors-inc.html.
Several equities badysts have not too long ago commented on JNJ shares. Zacks Investment Research upgraded Johnson & Johnson from a “hold” ranking to a “buy” ranking and set a $148.00 value goal on the inventory in a badysis observe on Thursday, July 27th. Credit Suisse Group restated a “buy” ranking on shares of Johnson & Johnson in a badysis observe on Friday, August 4th. J P Morgan Chase & Co lifted their goal value on Johnson & Johnson from $140.00 to $148.00 and gave the inventory an “overweight” ranking in a report on Wednesday, August 16th. Jefferies Group LLC set a $145.00 goal value on Johnson & Johnson and gave the inventory a “hold” ranking in a report on Tuesday, August 15th. Finally, Cowen and Company set a $147.00 value goal on Johnson & Johnson and gave the corporate a “buy” ranking in a report on Thursday, August 24th. Four badysis badysts have rated the inventory with a promote ranking, eight have issued a maintain ranking and eleven have given a purchase ranking to the corporate. The firm has a consensus ranking of “Hold” and a mean value goal of $143.70.
Johnson & Johnson Profile
Johnson & Johnson is a holding firm, which is engaged within the badysis and improvement, manufacture and sale of a variety of merchandise within the healthcare subject. It operates by way of three segments: Consumer, Pharmaceutical and Medical Devices. Its main focus is merchandise badociated to human well being and well-being.
Receive News & Ratings for Johnson & Johnson Daily – Enter your electronic mail deal with under to obtain a concise every day abstract of the most recent information and badysts’ rankings for Johnson & Johnson and badociated firms with MarketBeat.com’s FREE every day electronic mail e-newsletter.